BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simiczyjew A, Dratkiewicz E, Mazurkiewicz J, Ziętek M, Matkowski R, Nowak D. The Influence of Tumor Microenvironment on Immune Escape of Melanoma. Int J Mol Sci 2020;21:E8359. [PMID: 33171792 DOI: 10.3390/ijms21218359] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Q, Jin L, Jin Q, Wei Q, Sun M, Yue Q, Liu H, Li F, Li H, Ren X, Jin G. Inhibitory Effect of Dihydroartemisinin on the Proliferation and Migration of Melanoma Cells and Experimental Lung Metastasis From Melanoma in Mice. Front Pharmacol 2021;12:727275. [PMID: 34539408 DOI: 10.3389/fphar.2021.727275] [Reference Citation Analysis]
2 Pi YN, Qi WC, Xia BR, Lou G, Jin WL. Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential. Front Immunol 2021;12:697083. [PMID: 34295338 DOI: 10.3389/fimmu.2021.697083] [Reference Citation Analysis]
3 Melixetian M, Pelicci PG, Lanfrancone L. Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process. Cells 2022;11:577. [PMID: 35159386 DOI: 10.3390/cells11030577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Amalinei C, Grigoraș A, Lozneanu L, Căruntu I, Giușcă S, Balan RA. The Interplay between Tumour Microenvironment Components in Malignant Melanoma. Medicina 2022;58:365. [DOI: 10.3390/medicina58030365] [Reference Citation Analysis]
5 Zhao S, Xu B, Ma W, Chen H, Jiang C, Cai J, Meng X. DNA Damage Repair in Brain Tumor Immunotherapy. Front Immunol 2021;12:829268. [PMID: 35095931 DOI: 10.3389/fimmu.2021.829268] [Reference Citation Analysis]
6 Olszańska J, Pietraszek-Gremplewicz K, Nowak D. Melanoma Progression under Obesity: Focus on Adipokines. Cancers (Basel) 2021;13:2281. [PMID: 34068679 DOI: 10.3390/cancers13092281] [Reference Citation Analysis]
7 Takács A, Szász Z, Kalabay M, Bárány P, Csámpai A, Hegyesi H, Láng O, Lajkó E, Kőhidai L. The Synergistic Activity of Bortezomib and TIC10 against A2058 Melanoma Cells. Pharmaceuticals (Basel) 2021;14:820. [PMID: 34451917 DOI: 10.3390/ph14080820] [Reference Citation Analysis]
8 Schwab A, Loeck T, Najder-Nalepa K. STIM2: Redox-sensor and effector of the (tumor) microenvironment. Cell Calcium 2021;94:102335. [PMID: 33387846 DOI: 10.1016/j.ceca.2020.102335] [Reference Citation Analysis]
9 Tsubaki M, Genno S, Takeda T, Matsuda T, Kimura N, Yamashita Y, Morii Y, Shimomura K, Nishida S. Rhosin Suppressed Tumor Cell Metastasis through Inhibition of Rho/YAP Pathway and Expression of RHAMM and CXCR4 in Melanoma and Breast Cancer Cells. Biomedicines 2021;9:35. [PMID: 33406809 DOI: 10.3390/biomedicines9010035] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jęśkowiak I, Wiatrak B, Szeląg A, Mączyński M. Preclinical Study of Immunological Isoxazole Derivatives as a Potential Support for Melanoma Chemotherapy. Int J Mol Sci 2021;22:10920. [PMID: 34681580 DOI: 10.3390/ijms222010920] [Reference Citation Analysis]
11 Fromme JE, Zigrino P. The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance. Front Mol Biosci 2022;9:864302. [DOI: 10.3389/fmolb.2022.864302] [Reference Citation Analysis]
12 Dratkiewicz E, Simiczyjew A, Mazurkiewicz J, Ziętek M, Matkowski R, Nowak D. Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance. Cells 2021;10:862. [PMID: 33918883 DOI: 10.3390/cells10040862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sabbatino F, Liguori L, Pepe S, Ferrone S. Immune checkpoint inhibitors for the treatment of melanoma. Expert Opin Biol Ther 2022. [PMID: 35130816 DOI: 10.1080/14712598.2022.2038132] [Reference Citation Analysis]
14 Mazurkiewicz J, Simiczyjew A, Dratkiewicz E, Ziętek M, Matkowski R, Nowak D. Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy. Int J Mol Sci 2021;22:E529. [PMID: 33430277 DOI: 10.3390/ijms22020529] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
15 Cherepakhin OS, Argenyi ZB, Moshiri AS. Genomic and Transcriptomic Underpinnings of Melanoma Genesis, Progression, and Metastasis. Cancers (Basel) 2021;14:123. [PMID: 35008286 DOI: 10.3390/cancers14010123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shen H, Cai S, Wu C, Yang W, Yu H, Liu L. Recent Advances in Three-Dimensional Multicellular Spheroid Culture and Future Development. Micromachines (Basel) 2021;12:96. [PMID: 33477508 DOI: 10.3390/mi12010096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Minokawa Y, Sawada Y, Nakamura M. The Influences of Omega-3 Polyunsaturated Fatty Acids on the Development of Skin Cancers. Diagnostics (Basel) 2021;11:2149. [PMID: 34829495 DOI: 10.3390/diagnostics11112149] [Reference Citation Analysis]
18 Cerqueira OLD, Antunes F, Assis NG, Cardoso EC, Clavijo-salomón MA, Domingues AC, Tessarollo NG, Strauss BE. Perspectives for Combining Viral Oncolysis With Additional Immunotherapies for the Treatment of Melanoma. Front Mol Biosci 2022;9:777775. [DOI: 10.3389/fmolb.2022.777775] [Reference Citation Analysis]
19 Mazurkiewicz E, Makowiecka A, Mrówczyńska E, Kopernyk I, Nowak D, Mazur AJ. Gelsolin Contributes to the Motility of A375 Melanoma Cells and This Activity Is Mediated by the Fibrous Extracellular Matrix Protein Profile. Cells 2021;10:1848. [PMID: 34440617 DOI: 10.3390/cells10081848] [Reference Citation Analysis]
20 Sawada Y, Nakamura M. Daily Lifestyle and Cutaneous Malignancies. Int J Mol Sci 2021;22:5227. [PMID: 34069297 DOI: 10.3390/ijms22105227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Sadanandan N, Shear A, Brooks B, Saft M, Cabantan DAG, Kingsbury C, Zhang H, Anthony S, Wang ZJ, Salazar FE, Lezama Toledo AR, Rivera Monroy G, Vega Gonzales-Portillo J, Moscatello A, Lee JY, Borlongan CV. Treating Metastatic Brain Cancers With Stem Cells. Front Mol Neurosci 2021;14:749716. [PMID: 34899179 DOI: 10.3389/fnmol.2021.749716] [Reference Citation Analysis]
22 Novak D, Utikal J. Melanoma Cellular Plasticity. Int J Mol Sci 2022;23:6401. [PMID: 35742846 DOI: 10.3390/ijms23126401] [Reference Citation Analysis]
23 Kupczyk P, Simiczyjew A, Marczuk J, Dratkiewicz E, Beberok A, Rok J, Pieniazek M, Biecek P, Nevozhay D, Slowikowski B, Chodaczek G, Wrzesniok D, Nowak D, Donizy P. PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma-A Clinical and an In Vitro Study. Cells 2021;10:286. [PMID: 33572647 DOI: 10.3390/cells10020286] [Reference Citation Analysis]
24 Sawada Y, Mashima E, Saito-Sasaki N, Nakamura M. The Role of Cell Adhesion Molecule 1 (CADM1) in Cutaneous Malignancies. Int J Mol Sci 2020;21:E9732. [PMID: 33419290 DOI: 10.3390/ijms21249732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Romano V, Belviso I, Venuta A, Ruocco MR, Masone S, Aliotta F, Fiume G, Montagnani S, Avagliano A, Arcucci A. Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape. Int J Mol Sci 2021;22:5283. [PMID: 34067929 DOI: 10.3390/ijms22105283] [Cited by in F6Publishing: 1] [Reference Citation Analysis]